KBR Wins Contract for Sonangol's Refinery Project in Angola-February 2024-www.financetom.com

KBR Wins Contract for Sonangol's Refinery Project in Angola

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

KBR Wins Contract for Sonangol's Refinery Project in Angola

Mar 14, 2024 7:44 AM

10:27 AM EDT, 03/14/2024 (MT Newswires) -- KBR (KBR) said Thursday it received a contract from Sonangol to design and construct a new refinery in Lobito, Angola.

Under the terms, the company will offer engineering, procurement, and construction phase execution services, KBR added.

Financial terms of the contract weren't disclosed.

Price: 60.85, Change: -0.29, Percent Change: -0.47

Previous page： Alaska Air Group Q2 Adjusted Earnings Decline, Revenue Increases; Shares Slip After Hours Next page： --Carriage Services Keeps Quarterly Cash Dividend at $0.1125 a Share, Payable Sept. 3 to Holders as of Aug. 5

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Alaska Air Group Q2 Adjusted Earnings Decline, Revenue Increases; Shares Slip After Hours

Jul 17, 2024

05:52 PM EDT, 07/17/2024 (MT Newswires) -- Alaska Air Group ( ALK ) reported Q2 adjusted earnings late Wednesday of $2.55 per diluted share, down from $3 a year earlier. Analysts polled by Capital IQ expected $2.38. Revenue for the quarter that ended June 30 was $2.90 billion, up from $2.84 billion a year earlier. Analysts surveyed by Capital IQ...

--Carriage Services Keeps Quarterly Cash Dividend at $0.1125 a Share, Payable Sept. 3 to Holders as of Aug. 5

Jul 17, 2024

05:51 PM EDT, 07/17/2024 (MT Newswires) -- Price: 29.07, Change: +0.04, Percent Change: +0.14 ...

Ultragenyx Reports 'Successful' End-of-Phase 2 FDA Meeting For Angelman Syndrome Program

Jul 17, 2024

05:54 PM EDT, 07/17/2024 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) reported late Wednesday the successful completion of an end-of-phase 2 meeting with the US Food and Drug Administration, supporting its late-stage study plans for GTX-102 for Angelman syndrome. FDA alignment on our Phase 3 study design for GTX-102 allows for rapid initiation of a global double-blind sham-controlled pivotal...

ICF Tapped to Implement Commonwealth Edison Electrification Programs in Illinois

Jul 17, 2024

06:02 PM EDT, 07/17/2024 (MT Newswires) -- ICF (ICFI) late Wednesday said it has been selected to implement Commonwealth Edison's $231 million electrification programs to remove barriers and promote equitable access to electric vehicles in Illinois. The programs, with support provided by ICF and another energy efficiency firm, Walker-Miller Energy Services, will also help ComEd build out a charging network...